NCT04896996

The Effect of Continuous Egg Supplement on Personalized Nutri-omics in Primary School Children (SI-EGG STUDY)

Name: Clinical Trial NCT04896996
Creator: Mahidol University
Keywords: Malnutrition, Child, whole eggs, dietary supplement, clinical trial, Thailand

Mahidol University·ClinicalTrials.gov·dietary supplementCompleted

View on ClinicalTrials.gov →

Study focus

Disease/Condition: Malnutrition, Child
Drug/Device/Intervention: whole eggs
Study type: Interventional
Intervention type: dietary supplement

Sponsor & location

Primary sponsor: Mahidol University
Location: Bangkok Noi, Thailand

Timeline & enrollment

Phase: N/A
Start date: May 21, 2019
End date: Apr 29, 2020
Enrollment: 635 participants

Primary outcome

changes in body weight following the dietary intervention,changes in height following the dietary intervention,change in blood protein levels following dietary intervention,changes in blood biochemistries following dietary intervention

Summary

This research compares the effects of one-year continuous whole egg supplement vs. egg yolk substitutes and control on anthropometry, biochemical blood parameters, metabolic enzymes and microbiome data in primary school children.

ICD-10 classifications

MalnutritionMalnutrition in pregnancySequelae of malnutrition and other nutritional deficienciesMalnutrition-related diabetes mellitusMalnutrition-related diabetes mellitus with unspecified complications

Data source

Registry: ClinicalTrials.gov
Trial ID: NCT04896996
Type: Non-Device Trial

About this record

Access comprehensive clinical trial information for NCT04896996 through Pure Global AI's free database. This phase not specified trial is sponsored by Mahidol University and is currently Completed. The study focuses on Malnutrition, Child. Target enrollment is 635 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.